Business Context and Reporting Period
Company: Global Medical REIT Inc. (GMRE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: Global Medical REIT Inc. is an internally managed REIT that acquires healthcare facilities and leases them to physician groups and healthcare systems. As of June 30, 2024, the portfolio consisted of 184 buildings with approximately 4.7 million net leasable square feet. The company completed no acquisitions during the period but executed one disposition.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 |
|---|---|---|
| Total Revenue | $69.4 million | $72.6 million |
| Net Income (Loss) | $0.4 million | $16.4 million |
| Net Income Attributable to Common Stockholders | $(2.4) million | $12.5 million |
| Funds from Operations (FFO) | $28.8 million | $29.8 million |
| Adjusted FFO (AFFO) | $32.2 million | $31.8 million |
| Net Cash Provided by Operating Activities | $33.2 million | $33.6 million |
| Total Debt (Net) | $613.7 million | $611.2 million |
| Cash and Restricted Cash | $7.8 million | $9.8 million |
| Weighted Average Interest Rate | 3.89% | 3.83% |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by $3.2 million (4.4%) compared to the prior year, primarily due to the impact of three property dispositions completed in 2023.
- Net Income Volatility: Net income dropped significantly from $16.4 million to $0.4 million. This was driven by a $3.4 million loss on the sale of an in-patient rehabilitation facility in June 2024, contrasting with a $13.3 million gain on property sales in the same period of 2023.
- Interest Expense Reduction: Interest expense decreased by $2.9 million to $13.9 million, attributed to lower average borrowings and favorable interest rate swaps, despite elevated SOFR rates.
- Portfolio Activity: The company sold one facility (Mishawaka, Indiana) for $8.1 million gross proceeds. No acquisitions were completed during the six-month period.
Outlook, Risks, and Management Commentary
- Acquisition Pipeline: In May 2024, the company entered an agreement to acquire a 15-property portfolio. Five properties were acquired in July 2024 for $30.8 million, with the remaining 10 properties expected to close in Q4 2024 for $49.5 million.
- Capital Markets: The company implemented a $300 million "at-the-market" (ATM) equity program in January 2024 but sold no shares during the period. Unutilized borrowing capacity under the Credit Facility revolver was $261 million as of August 5, 2024.
- Interest Rate Environment: Management notes that elevated interest rates and a "wait-and-see" approach by the Federal Reserve have increased the cost of capital, limiting the ability to acquire assets meeting investment requirements. The company utilizes interest rate swaps to fix the SOFR component of its term loans.
- Risk Factors: Key risks include tenant defaults, non-renewal of leases, healthcare wage inflation impacting tenant creditworthiness, and the potential inability to refinance debt on favorable terms.
Investor Verification Checklist
- Disposition Loss Impact: Verify the long-term strategic impact of the $3.4 million loss on the Mishawaka facility sale and whether it signals a shift in portfolio strategy.
- Acquisition Closing: Monitor the closing of the remaining 10 properties in the 15-property portfolio scheduled for Q4 2024 and the associated financing terms.
- Debt Maturities: Review the maturity schedule for the $105 million revolver and Term Loan A ($350 million), noting that $200 million of interest rate swaps mature in August 2024.
- Tenant Concentration: Confirm that no single tenant exceeds 10% of rental revenue, as reported, and assess the credit quality of major healthcare system tenants amidst wage inflation.
- Dividend Coverage: Analyze AFFO coverage of the $0.42 per share annual common dividend and $1.875 per share annual preferred dividend to ensure sustainability given the net loss.